Pharmacy Drugs
Recent Posts
- Lytix Biopharma AS Announces Regulatory Approval By Norwegian And Swedish Authorities To Commence Phase I Clinical Trial Of OncoporeTM In Cancer
- NPA Responds To Quality Accounts Consultation, UK
- Novelos Therapeutics’ (NVLT.OB) CEO Is Eyeing “Revolutionary” Phase III Study Results
- Investigational Dual Orexin Receptor Antagonist Almorexant Meets Primary Endpoint In Two-week Phase III Study Of Primary Insomnia
- PHT Corporation’s Market Leading LogPad And StudyWorksTM EPRO Solutions Used In Sanofi Pasteur’s Phase II Study Of New Clostridium Difficile Vaccine
Random Posts
- Survey Emphasises Need For OLS Plans To Become Reality, UK
- Pharmacies Urged To Register From 1 - 31 July 2009 To Receive Early-bird Payment
- Clinical Trials For Shingles Drug Take An Important Step Forward
- Report Finds Racial Disparities In Prescription Drug Access, Use, Regimen Adherence
- Link Between Vitamin D And Reduction In Multiple Sclerosis Risk
- Néovacs To Expand Clinical Testing Of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings From A Phase I/II Study
- New Therapy Improves Chances Of Living Disease-free With Difficult-to-treat Childhood Cancer
- Electronic Prior Authorization Program To Help Patients Get Faster Access To Prescription Medication
- Study Uncovers How Tiny Levels Of Carbon Monoxide Damage Fetal Brain
- Conflict Of Interest Reported In 29 Percent Of Cancer Studies
Ian Facer Is New Chairman Of The National Pharmacy Association (NPA), UK
Posted by: admin in Pharmacy Drugs on November 22nd, 2009
The NPA is delighted to announce that the Board of Management has chosen Ian Facer MRPharmS to chair the Association for 2009-2010.
Ian Facer joined the NPA Board of Management in 2004 representing NPA members in the North West and owns his own community pharmacy in Lancashire.
Ian will be joined by the newly elected Vice-Chairman, David Evans, and Wally Dove, who has been reappointed Treasurer.
Accepting his new position Ian said:
“Much has been achieved over the last twelve months and I would like to thank outgoing Chairman Paul Bennett for the work he has done to improve the collaborative efforts between the pharmacy bodies and the personal time and energy he has put in to leading this Board over the last 12 months and overseeing the strategic plans of our Chief Executive.
“We have an excellent chief executive in John Turk who has a clear sense of direction both for the NPA and community pharmacy. John’s policy of fast evolution at the NPA is a correct one and will continue under my tenure.
Within that I believe there are three key areas of work:
We need to raise the profile of the Association even further, if an issue is of concern to our members then we should champion that cause robustly and vocally.
The Pharmacy White Paper, a landmark policy document, needs to be implemented and we must continue our collaborative working with the other representative bodies to achieve this end.
And we need to support our members in the legislative changes taking place - the responsible pharmacist, supervision, revalidation, and skill mix. - all substantive pieces of work in their own right, combined they make up a very full agenda.
Finally, and most importantly, we need to engage the whole of our membership across the whole of the UK and provide leadership. People trust the NPA and have an innate affection for the Association. We have a chief executive who has the skills to make the most of what is already a valued resource and I hope that with my support we will maximise the return on the investment our members have made in the NPA.”
And adds:
“As I write, community pharmacy is preparing for the impact of a potential flu pandemic. However, the work the NPA and others in pharmacy have done has ensured we are both informed by Government and prepared as a profession for whatever eventualities lie ahead. I am confident that our preparations will allow us to provide maximum support to the NHS, patients and the public if a pandemic is confirmed.”
Notes
Ian Facer BPharm(Hons) MRPharmS studied at Chelsea College qualifying in 1986 following a pre-registration period with Boots in Holborn. Ian joined the family business in 1987 and now manages this and an Optician’s practice with his wife who is also a pharmacist. Vice Chairman of Central Lancashire LPC, Past Chairman of Central Lancashire branch of the RPSGB, and former PEC pharmacist at Chorley and South Ribble PCT. Ian Represents the Northwest Area and joined the Board in 2004.
Ian will lead a board with a diverse membership, covering independents, independently owned multiples and corporate multiples.
Source
National Pharmacy Association